These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18830558)

  • 1. Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes.
    Ikeda Y; Inoue M; Suehiro T; Arii K; Kumon Y; Hashimoto K
    Acta Diabetol; 2009 Sep; 46(3):239-42. PubMed ID: 18830558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes.
    Inoue M; Suehiro T; Nakamura T; Ikeda Y; Kumon Y; Hashimoto K
    Metabolism; 2000 Nov; 49(11):1400-5. PubMed ID: 11092501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
    Jornayvaz FR; Brulhart-Meynet MC; James RW
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):613-9. PubMed ID: 19201174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human serum paraoxonase concentration predicts cardiovascular mortality in hemodialysis patients.
    Ikeda Y; Suehiro T; Itahara T; Inui Y; Chikazawa H; Inoue M; Arii K; Hashimoto K
    Clin Nephrol; 2007 Jun; 67(6):358-65. PubMed ID: 17598371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
    Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
    Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in paraoxonase-1 activity and atherosclerosis.
    Soran H; Younis NN; Charlton-Menys V; Durrington P
    Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients.
    Boemi M; Sirolla C; Testa R; Cenerelli S; Fumelli P; James RW
    Diabet Med; 2004 May; 21(5):423-7. PubMed ID: 15089785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
    Kotur-Stevuljevic J; Spasic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Stefanovic A; Vujovic A; Memon L; Kalimanovska-Ostric D
    Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of oxidative stress and paraoxonase status with PROCAM risk score.
    Stefanović A; Kotur-Stevuljević J; Spasić S; Vekic J; Bujisić N
    Clin Biochem; 2009 May; 42(7-8):617-23. PubMed ID: 19318033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities.
    Rock W; Rosenblat M; Miller-Lotan R; Levy AP; Elias M; Aviram M
    J Agric Food Chem; 2008 Sep; 56(18):8704-13. PubMed ID: 18759451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan.
    Li WF; Sun CW; Cheng TJ; Chang KH; Chen CJ; Wang SL
    Toxicol Appl Pharmacol; 2009 Apr; 236(2):246-53. PubMed ID: 19371607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study).
    van den Berg SW; Jansen EH; Kruijshoop M; Beekhof PK; Blaak E; van der Kallen CJ; van Greevenbroek MM; Feskens EJ
    Diabet Med; 2008 Feb; 25(2):186-93. PubMed ID: 18290860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
    Garin MC; James RW; Dussoix P; Blanché H; Passa P; Froguel P; Ruiz J
    J Clin Invest; 1997 Jan; 99(1):62-6. PubMed ID: 9011577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
    Li C; Gu Q
    Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
    Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum paraoxonase-I activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Voorbij HA; Sluiter WJ; van Tol A
    Eur J Clin Invest; 2009 Mar; 39(3):200-3. PubMed ID: 19260949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waist circumference as a cardiovascular and metabolic risk in Japanese patients with type 2 diabetes.
    Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Ishibashi S; Oikawa S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N
    Obesity (Silver Spring); 2009 Mar; 17(3):585-92. PubMed ID: 19023281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.